Global Leukocyte Surface Antigen CD47 Market By Type (B-6H12, ALX-148, CC-90002, and PSTx-23), By Application (Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury, and Kindney Transplant Rejection), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028

Published date: Aug 2022
Report ID: 35657
Number of Pages: 216
Format:

- 1. Leukocyte Surface Antigen CD47 Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Leukocyte Surface Antigen CD47 Market Overview
  - 3.1. Leukocyte Surface Antigen CD47 Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Production Analysis by Region/Company
  - 3.9. Industry chain Analysis
  - 3.10. Marketing Strategy
- 4. Global Leukocyte Surface Antigen CD47 Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Leukocyte Surface Antigen CD47 Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. B-6H12
  - 4.4. ALX-148
  - 4.5. CC-90002
  - 4.6. PSTx-23
- 5. Global Leukocyte Surface Antigen CD47 Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Leukocyte Surface Antigen CD47 Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Lymphoma
  - 5.4. Ovarian Cancer
  - 5.5. Ischemia Reperfusion Injury
  - 5.6. Kindney Transplant Rejection
- 6. Global Leukocyte Surface Antigen CD47 Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Leukocyte Surface Antigen CD47 Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2.1. Europe
    6.2.1. Europe Leukocyte Surface Antigen CD47 Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Leukocyte Surface Antigen CD47 Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific
  - 6.4. Latin America
    6.4.1. Latin America Leukocyte Surface Antigen CD47 Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Leukocyte Surface Antigen CD47 Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Leukocyte Surface Antigen CD47 Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Aurigene Discovery Technologies Ltd
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Celgene Corp
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. Forty Seven Inc
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Surface Oncology Inc
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Trillium Therapeutics Inc
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Aurigene Discovery Technologies Ltd
- Celgene Corp
- Forty Seven Inc
- Surface Oncology Inc
- Trillium Therapeutics Inc
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)